Table 4. The correlation of three lncRNAs and risk score with clinicopathological parameters (TCGA dataset, N = 449).
Clinicopathological parameters | AC079630.2 (P) | CRNDE (P) | CTD-2171N6.1 (P) | Risk score (P) |
---|---|---|---|---|
Age | 0.122 | 0.115 | 0.092 | 0.004 |
Gender | 0.602 | 0.016 | 0.077 | 0.963 |
Tumor subtypes | 0.508 | 0.226 | 0.001 | 0.013 |
History of other tumor | 0.71 | 0.265 | 0.237 | 0.226 |
Pathological stage | 0.598 | 0.074 | 0.523 | 0.319 |
T stage | 0.612 | 0.346 | 0.342 | 0.303 |
N stage | 0.057 | 0.698 | 0.062 | 0.308 |
M stage | 0.805 | 0.209 | 0.137 | 0.173 |
Focus types | 0.261 | 0.922 | 0.393 | 0.971 |
Extrathyroidal extension | 0.666 | 0.251 | 0.264 | 0.872 |
BRAFV600E | 0.982 | 0.105 | 0.045 | 0.006 |
P: P- values of Spearman rank correlation.